Cargando…

Potential effects of brain lipid binding protein in the pathogenesis of amyotrophic lateral sclerosis

Current studies suggest that the abnormal alteration of brain lipid binding protein (BLBP) might participate in the pathogenesis of amyotrophic lateral sclerosis (ALS). However, the detailed understanding of ALS pathogenesis been yet to be elucidated. Therefore, this research intended to explore the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Qi, Kang, Qing, Chen, Wenzhi, Xu, Renshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Medicine & Health Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10358493/ https://www.ncbi.nlm.nih.gov/pubmed/37439013 http://dx.doi.org/10.1177/00368504231184320

Ejemplares similares

Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis
por: Zhou, Wan, et al.
Publicado: (2023)

Editorial: New Insights Into the Molecular Mechanism of Amyotrophic Lateral Sclerosis Pathogenesis
por: Li, Cheng, et al.
Publicado: (2022)

Involvement of Lipids in the Pathogenesis of Amyotrophic Lateral Sclerosis
por: Alessenko, Alisa V., et al.
Publicado: (2023)

Potential Common Genetic Risks of Sporadic Parkinson’s Disease and Amyotrophic Lateral Sclerosis in the Han Population of Mainland China
por: Lu, Yi, et al.
Publicado: (2021)

The pathogenic mechanism of TAR DNA-binding protein 43 (TDP-43) in amyotrophic lateral sclerosis
por: Wang, Xinxin, et al.
Publicado: (2023)

288 Harnessing the potential of transcriptional adaptation as a mechanism for Amyotrophic lateral sclerosis
por: Gomez, Adriana Morales, et al.
Publicado: (2023)

Mitochondrial dynamism and the pathogenesis of Amyotrophic Lateral Sclerosis
por: Cozzolino, Mauro, et al.
Publicado: (2015)

Identification of an immune-related gene prognostic index for predicting prognosis, immunotherapeutic efficacy, and candidate drugs in amyotrophic lateral sclerosis
por: Wei, Caihui, et al.
Publicado: (2022)

Aberrant Levels of Cystatin C in Amyotrophic Lateral Sclerosis: a Systematic Review and Meta Analysis
por: Zhu, Yu, et al.
Publicado: (2018)

25-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis
por: Kim, Sung-Min, et al.
Publicado: (2017)

Lipid Biomarkers for Amyotrophic Lateral Sclerosis
por: González De Aguilar, Jose-Luis
Publicado: (2019)

RNA-Binding Proteins in Amyotrophic Lateral Sclerosis
por: Zhao, Melody, et al.
Publicado: (2018)

Metabolic Dysfunctions in Amyotrophic Lateral Sclerosis Pathogenesis and Potential Metabolic Treatments
por: Tefera, Tesfaye W., et al.
Publicado: (2017)

Molecular Investigations of Protein Aggregation in the Pathogenesis of Amyotrophic Lateral Sclerosis
por: Duranti, Elisa, et al.
Publicado: (2022)

Retromer dysfunction in amyotrophic lateral sclerosis
por: Pérez-Torres, Eduardo J., et al.
Publicado: (2022)

Identification of Molecular Correlations Between DHRS4 and Progressive Neurodegeneration in Amyotrophic Lateral Sclerosis By Gene Co-Expression Network Analysis
por: Li, Shu, et al.
Publicado: (2022)

Mitochondrial Transport and Turnover in the Pathogenesis of Amyotrophic Lateral Sclerosis
por: Granatiero, Veronica, et al.
Publicado: (2019)

Diagnostic Circulating miRNAs in Sporadic Amyotrophic Lateral Sclerosis
por: Panio, A., et al.
Publicado: (2022)

Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis
por: Ingre, Caroline, et al.
Publicado: (2020)

RNA-Binding Proteins in Amyotrophic Lateral Sclerosis and Neurodegeneration
por: Ugras, Scott E., et al.
Publicado: (2012)

Dysregulation of RNA-Binding Proteins in Amyotrophic Lateral Sclerosis
por: Xue, Yuan Chao, et al.
Publicado: (2020)

Circulating NAD+ Metabolism-Derived Genes Unveils Prognostic and Peripheral Immune Infiltration in Amyotrophic Lateral Sclerosis
por: Li, Cheng, et al.
Publicado: (2022)

Massive Incidental Pneumoperitoneum in an Amyotrophic Lateral Sclerosis Patient
por: Jaber, Jasmin, et al.
Publicado: (2021)

Riluzole and Edavarone: The Hope Against Amyotrophic Lateral Sclerosis
por: Rokade, Aditi V, et al.
Publicado: (2022)

Misfolding at the synapse: A role in amyotrophic lateral sclerosis pathogenesis?
por: Lum, Jeremy S., et al.
Publicado: (2022)

Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis
por: Genin, Emmanuelle C., et al.
Publicado: (2023)

Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis
por: Phan, Katherine, et al.
Publicado: (2022)

Glutathionylation on RNA-binding proteins: a regulator of liquid‒liquid phase separation in the pathogenesis of amyotrophic lateral sclerosis
por: Choi, Hyun-Jun, et al.
Publicado: (2023)

γ' Fibrinogen as a Predictor of Survival in Amyotrophic Lateral Sclerosis
por: Pronto-Laborinho, Ana Catarina, et al.
Publicado: (2021)

Ethnical Disparities in Response to Edaravone in Patients With Amyotrophic Lateral Sclerosis
por: Jayasinghe, Maleesha, et al.
Publicado: (2022)

A Protocol for Comprehensive Assessment of Bulbar Dysfunction in Amyotrophic Lateral Sclerosis (ALS)
por: Yunusova, Yana, et al.
Publicado: (2011)

SOD1 misplacing and mitochondrial dysfunction in amyotrophic lateral sclerosis pathogenesis
por: Tafuri, Francesco, et al.
Publicado: (2015)

Molecular Chaperones in the Pathogenesis of Amyotrophic Lateral Sclerosis: The Role of HSPB1
por: Capponi, Simona, et al.
Publicado: (2016)

Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis
por: Nakazawa, Seshiru, et al.
Publicado: (2016)

Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?
por: Trojsi, Francesca, et al.
Publicado: (2020)

Muscle Involvement in Amyotrophic Lateral Sclerosis: Understanding the Pathogenesis and Advancing Therapeutics
por: Duranti, Elisa, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Digital health solution for monitoring and surveillance of Amyotrophic Lateral Sclerosis in Brazil
por: Barbalho, Ingridy M. P., et al.
Publicado: (2023)

The Potential Role of Cytotoxic Immune Effectors in Induction, Progression and Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)
por: Kaur, Kawaljit, et al.
Publicado: (2022)

Rofecoxib Attenuates the Pathogenesis of Amyotrophic Lateral Sclerosis by Alleviating Cyclooxygenase-2-Mediated Mechanisms
por: Zou, Yan-Hui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qevv4dggl7febrvg7uofif3mol